![]() Electronic Skin Patch Market Set to Reach $27 Billion by 2029The global Electronic Skin Patch Market was valued at USD 15.0 billion in 2024 and is projected to grow from USD 16.63 billion in 2025 to USD 27.0 billion by 2029
By: MarketsandMarkets By segment, electronic skin patch industry for monitoring & diagnostic are projected to grow at a high CAGR during the forecast period. In recent years, there has been a significant shift toward developing and using electronic skin patches for monitoring and diagnosis in healthcare. These patches come with various features, including sensors for physiological measurements, biomarker detection, and data transmission via wireless connectivity. By segment, electronic skin patch industry for Connected electronic skin patches in Wireless Connectivity is expected to account largest share during the forecast period. Connected patches are expected to dominate due to their advanced functionalities and integration with remote healthcare solutions, non-connected patches will continue to gain popularity due to their affordability and data privacy advantages. Technologies integrated in connected electronic skin patches include Ethernet, cellular, Wi-Fi, near-field communication (NFC), and Bluetooth. The Bluetooth Low Energy (BLE) technology strikes a balance between power consumption and data transmission range, making it suitable for applications where real-time data is not crucial, such as monitoring glucose levels for people with diabetes or tracking sleep patterns. By segment, electronic skin patch industry for Diabetes Management will account for largest share during the forecast period. Electronic skin patches are revolutionizing the management of diabetes, a chronic condition that affects a significant and growing population worldwide. According to the Institute for Health Metrics and Evaluation (IHME), the number of global diabetes cases is projected to increase from 529 million in 2023 to 1.3 billion by 2050. This makes it essential to have non-invasive and continuous monitoring approaches to manage blood sugar levels effectively in real time, improving patient outcomes. Dexcom ONE+ is a customizable continuous glucose monitoring (CGM) solution launched in February 2024, designed to enhance diabetes management. It comprises a water-resistant sensor for blood glucose measurement, a transmitter for CGM data transmission, and a smartphone-compatible app for real-time monitoring. For more info: https://www.marketsandmarkets.com/ End
|
|